Amgen and GSK said to be adding products on TrumpRx
Source: SeekingAlpha
2026-03-14 09:48:29 ET
More on GSK, Amgen
- Amgen: MariTide And Osteoporosis Sales Fuel The Rally
- GSK plc (GSK) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
- Amgen Inc. (AMGN) Presents at Leerink Global Healthcare Conference 2026 Transcript
- GSK wins FDA label expansion for RSV vaccine, Arexvy
- GSK gains approval of leucovorin for rare genetic disorder
Read the full article on Seeking Alpha
For further details see:
Amgen and GSK said to be adding products on TrumpRx
GlaxoSmithKline PLC
NASDAQ: GSK
GSK Trading
1.0% G/L:
$52.43 Last:
882,682 Volume:
$52.19 Open:
GSK Latest News
March 13, 2026 11:44:00 am
GSK's RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18-49 Years at Increased Risk
February 23, 2026 01:13:00 pm
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
GSK Stock Data
$120,291,791,432
2,019,018,428
0.4%
538
N/A
Pharmaceuticals
Healthcare
GB
London
